The Hillingdon Hospitals NHS Foundation Trust

Specialist MDT: Imperial College Healthcare NHS Trust

View Provider Services

The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
    • Joint specialist MDT clinic
    • Clinical trials unit
  • Support Service Facilities:
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Specialist continence services
    • Psychological counselling

Data Quality

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 223 1438
Performance Status recorded 88% 84%
TNM completed 62% 50%
Stage variable assigned 87% 77%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 776 34801
Percentage of men diagnosed with metastatic disease 11% 13%

Management

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset